We are live on ! Find out more
ELOS

Syneron Medical
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

68 hedge funds and large institutions have $252M invested in Syneron Medical in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

5% more funds holding

Funds holding: 65 → 68 (+3)

3% more capital inflows, than outflows

Capital inflows: $14.5M | Capital outflows: $14.2M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
68
Holders Change
+3
Holders Change %
+4.62%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
19
Reduced
15
Closed
10
Calls
$37​K
Puts
–
Net Calls
+$37​K
Net Calls Change
-⁠$644​K

ELOS Hedge Fund Activity: Q4 2014 in Review

68 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical (ELOS) for Q4 2014, worth a combined $252M — down 6.7% from $270M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ELOS positions and 10 closed out — a net gain of 4 holders — while 19 added to existing stakes and 15 trimmed.

The largest buyer was Senzar Asset Management, opening a new position worth an estimated $2.9M. The largest seller was Baupost Group, cutting an estimated $5.58M.

  • 68 institutional investors held Syneron Medical (ELOS) as of Q4 2014, up from 65 in Q3 2014.
  • Funds reported $252M of Syneron Medical stock for Q4 2014, down 6.7% quarter-over-quarter.
  • 14 funds opened new Syneron Medical positions in Q4 2014 and 10 closed out, a net change of +4 holders.
  • The largest Syneron Medical buyer in Q4 2014 was Senzar Asset Management, an estimated $2.9M added.
  • The largest Syneron Medical seller in Q4 2014 was Baupost Group, an estimated $5.58M sold.

Based on aggregated 13F filings for Q4 2014.